Asia Pacific single cell multiomics market will grow by 21.8% annually with a total addressable market cap of $ 16,032.0 million over 2022-2031, driven by the rising prevalence of chronic diseases along with the aging population, the widespread product adoption for visualization and analysis, technological advancements along with the rising R&D investment, and the significant growth in the pharmaceutical industry especially personalized medication.
Highlighted with 36 tables and 76 figures, this 149-page report “Asia Pacific Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific single cell multiomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific single cell multiomics market in every aspect of the classification from perspectives of Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Country.
Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Instruments
• Consumables
• Software
Based on Omics Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Single Cell Genomics (SCG)
• Single Cell Transcriptomics (SCT)
• Single Cell Proteomics (SCP)
• Single Cell Metabolomics (SCM)
By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Clinical Research
o Oncology
o Cell Therapy
o Immunology
o Neurology
o Cell Biology
o Other Types of Clinical Research
• Translation Research
• Synthetic Biology
By Sample Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Human Samples
o Cancer Tissues
o Stem Cells
o Immune Cells
o Brain Cells
o Other Human Samples
• Animal Samples
• Microbial Samples
By Workflow, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Single-Cell Isolation and Dispensing
o Fluorescence-Activated Cell Sorting (FACS)
o Microfluidics
o Magnetic-Activated Cell Sorting (MACS)
o Random Seeding
o Manual Cell Picking
o Laser Capture Microdissection
o Other Technologies of Single-Cell Isolation and Dispensing
• Single-Cell Analysis
o Polymerase Chain Reaction
o Next-Generation Sequencing
o Mass Cytometry
o Mass Spectrometry
o Other Technologies of Single-Cell Analysis
By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Research and Academic Laboratories
• Biopharmaceutical and Biotech Companies
• Contract Research Organizations (CROs)
• Other End Users
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Omics Type, Workflow and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
10x Genomics, Inc.
1CellBio, Inc.
Becton, Dickinson and Company
Berkeley Lights, Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
BioTuring, Inc.
Danaher Corporation (Cytiva Life Sciences)
Dolomite Bio
Fluidigm Corporation
Fluxion Biosciences
Illimina, Inc
Mission Bio, Inc.
Namocell, Inc.
NanoString Technologies, Inc.
Parse Biosciences, Inc.
Proteona
Qiagen N.V.
RareCyte, Inc.
Scipio Biosciences SAS
Shilps Sciences
Takara Bio Inc. (Takara Holdings)
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 35
2.4 Emerging Opportunities and Market Trends 38
2.5 Porter’s Fiver Forces Analysis 42
3 Segmentation of Asia Pacific Market by Product Type 46
3.1 Market Overview by Product Type 46
3.2 Instruments 48
3.3 Consumables 49
3.4 Software 50
4 Segmentation of Asia Pacific Market by Omics Type 51
4.1 Market Overview by Omics Type 51
4.2 Single Cell Genomics (SCG) 53
4.3 Single Cell Transcriptomics (SCT) 54
4.4 Single Cell Proteomics (SCP) 55
4.5 Single Cell Metabolomics (SCM) 56
5 Segmentation of Asia Pacific Market by Application 57
5.1 Market Overview by Application 57
5.2 Clinical Research 59
5.2.1 Oncology 61
5.2.2 Cell Therapy 62
5.2.3 Immunology 63
5.2.4 Neurology 64
5.2.5 Cell Biology 65
5.2.6 Other Types of Clinical Research 66
5.3 Translation Research 67
5.4 Synthetic Biology 68
6 Segmentation of Asia Pacific Market by Sample Type 69
6.1 Market Overview by Sample Type 69
6.2 Human Samples 71
6.2.1 Cancer Tissues 73
6.2.2 Stem Cells 74
6.2.3 Immune Cells 75
6.2.4 Brain Cells 76
6.2.5 Other Human Samples 77
6.3 Animal Samples 78
6.4 Microbial Samples 79
7 Segmentation of Asia Pacific Market by Workflow 80
7.1 Market Overview by Workflow 80
7.2 Single-Cell Isolation and Dispensing 82
7.2.1 Fluorescence-Activated Cell Sorting (FACS) 84
7.2.2 Microfluidics 85
7.2.3 Magnetic-Activated Cell Sorting (MACS) 86
7.2.4 Random Seeding 87
7.2.5 Manual Cell Picking 88
7.2.6 Laser Capture Microdissection 89
7.2.7 Other Technologies of Single-Cell Isolation and Dispensing 90
7.3 Single-Cell Analysis 91
7.3.1 Polymerase Chain Reaction 93
7.3.2 Next-Generation Sequencing 94
7.3.3 Mass Cytometry 95
7.3.4 Mass Spectrometry 96
7.3.5 Other Technologies of Single-Cell Analysis 97
8 Segmentation of Asia Pacific Market by End User 98
8.1 Market Overview by End User 98
8.2 Research and Academic Laboratories 100
8.3 Biopharmaceutical and Biotech Companies 101
8.4 Contract Research Organizations (CROs) 102
8.5 Other End Users 103
9 Asia-Pacific Market 2021-2031 by Country 104
9.1 Overview of Asia-Pacific Market 104
9.2 Japan 107
9.3 China 110
9.4 Australia 112
9.5 India 114
9.6 South Korea 116
9.7 Rest of APAC Region 118
10 Competitive Landscape 120
10.1 Overview of Key Vendors 120
10.2 New Product Launch, Partnership, Investment, and M&A 123
10.3 Company Profiles 124
10x Genomics, Inc. 124
1CellBio, Inc. 126
Becton, Dickinson and Company 127
Berkeley Lights, Inc. 128
BGI Genomics Co., Ltd. 129
Bio-Rad Laboratories, Inc. 130
Bio-Techne Corporation 131
BioTuring, Inc. 132
Danaher Corporation (Cytiva Life Sciences) 133
Dolomite Bio 134
Fluidigm Corporation 135
Fluxion Biosciences 136
Illimina, Inc 137
Mission Bio, Inc. 138
Namocell, Inc. 139
NanoString Technologies, Inc. 140
Parse Biosciences, Inc. 141
Proteona 142
Qiagen N.V. 143
RareCyte, Inc. 144
Scipio Biosciences SAS 145
Shilps Sciences 146
Takara Bio Inc. (Takara Holdings) 147
Thermo Fisher Scientific Inc. 148
RELATED REPORTS 149
List of Tables:
Table 1. Snapshot of Asia Pacific Single Cell Multiomics Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. World Economic Outlook, 2021-2023 23
Table 4. Comparison of Rare Disease in Different Countries 32
Table 5. World Health Spending by Region, $ bn, 2013-2020 34
Table 6. Main Product Trends and Market Opportunities in Asia Pacific Single Cell Multiomics Market 38
Table 7. Asia Pacific Single Cell Multiomics Market by Product Type, 2021-2031, $ mn 46
Table 8. Asia Pacific Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 51
Table 9. Asia Pacific Single Cell Multiomics Market by Application, 2021-2031, $ mn 57
Table 10. Asia Pacific Single Cell Multiomics Market: Clinical Research by Type, 2021-2031, $ mn 60
Table 11. Asia Pacific Single Cell Multiomics Market by Sample Type, 2021-2031, $ mn 69
Table 12. Asia Pacific Single Cell Multiomics Market: Human Samples by Type, 2021-2031, $ mn 72
Table 13. Asia Pacific Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 80
Table 14. Asia Pacific Single Cell Multiomics Market: Single-Cell Isolation and Dispensing by Technology, 2021-2031, $ mn 83
Table 15. Asia Pacific Single Cell Multiomics Market: Single-Cell Analysis by Technology, 2021-2031, $ mn 92
Table 16. Asia Pacific Single Cell Multiomics Market by End User, 2021-2031, $ mn 98
Table 17. APAC Single Cell Multiomics Market by Country, 2021-2031, $ mn 105
Table 18. Japan Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 109
Table 19. Japan Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 109
Table 20. Japan Single Cell Multiomics Market by End User, 2021-2031, $ mn 109
Table 21. China Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 111
Table 22. China Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 111
Table 23. China Single Cell Multiomics Market by End User, 2021-2031, $ mn 111
Table 24. Australia Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 113
Table 25. Australia Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 113
Table 26. Australia Single Cell Multiomics Market by End User, 2021-2031, $ mn 113
Table 27. India Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 115
Table 28. India Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 115
Table 29. India Single Cell Multiomics Market by End User, 2021-2031, $ mn 115
Table 30. South Korea Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 117
Table 31. South Korea Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 117
Table 32. South Korea Single Cell Multiomics Market by End User, 2021-2031, $ mn 117
Table 33. Single Cell Multiomics Market in Rest of APAC by Country/Region, 2021-2031, $ mn 119
Table 34. 10x Genomics, Inc.: Company Snapshot 124
Table 35. 10x Genomics, Inc.: Business Segmentation 125
Table 36. 10x Genomics, Inc.: Product Portfolio 125
